Worst Performing Biotechnology Stocks Last 12 Months

Research the worst performing Biotechnology stocks for the past 12 months. 100% free, 20 years of data! News ... The worst performing biotechnology stock in the world for the past 12 months …

100%
OFF

Worst Performing Biotechnology Stocks Last 12 Months

2 weeks from now

Research the worst performing Biotechnology stocks for the past 12 months. 100% free, 20 years of data! News ... The worst performing biotechnology stock in the world for the past 12 months …

financecharts.com

100%
OFF

Worst Performing Biotech Stocks Last 12 Months

2 weeks from now

Research the worst performing Biotech stocks for the past 12 months. 100% free, 20 years of data! ... Worst Performing Biotech Stocks Last 12 Months. The worst performing biotech stock …

financecharts.com

100%
OFF

Worst Performing Stocks Last 12 Months - FinanceCharts.com

2 weeks from now

Jan 3, 2025 · Research the worst performing stocks for the past 12 months. 100% free, 20 years of data! News ... The worst performing stock for the past 12 months is QXO (QXO) with a total …

financecharts.com

5%
OFF

Worst Performing Biotech Stocks In Nasdaq Global Market In Last …

2 weeks from now

Allarity Therapeutics (ALLR) has had the lowest return since October 1, 2023 by a US stock in the Biotechnology Industry and the Nasdaq Composite (IXIC), returning -99.5%.

statmuse.com

35%
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · Despite Street analysts’ consensus Buy rating on CYTK, it is one of the worst performing biotech stocks on our list with a year-to-date decline of nearly 35%. 2. BridgeBio …

insidermonkey.com

9%
OFF

Worst Performing Stock Biotech Stock In 2024 | StatMuse Money

2 weeks from now

Aditxt has had the lowest return this year by a US stock or US stock in the Biotechnology Industry, returning -99.9%. ASSET YEAR % RETURN ; Aditxt (ADTX) 2024-99.91%. ... What was the …

statmuse.com

100%
OFF

Worst Performing Pharmaceutical Biotechnology Stocks Last 12 …

2 weeks from now

Research the worst performing Pharmaceutical Biotechnology stocks for the past 12 months. 100% free, 20 years of data! Popular Screeners Screens Custom Screener Biggest …

financecharts.com

4%
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · In Q3 2024, Cytokinetics reported revenue of nearly $0.5 million, which saw a 22.4% growth from the same period last year. The company’s cash position also remained …

insidermonkey.com

16%
OFF

Biotech Stocks Put Up A Mixed Showing At JPM; BridgeBio, …

2 weeks from now

2 days ago · NOW PLAYING Biotech Stocks Are Shooting Higher. Here's How You Can Play Them. BridgeBio stock ramped up 16% to 33.73, while ARS shares pulled back from steeper …

investors.com

$10
OFF

The 5 Worst-performing Stocks On The Dow Jones Industrial …

2 weeks from now

Jan 1, 2025 · TheStreet Pro Login Subscribe Portfolio (AAP) Latest (All Real Money Pro Authors) Doug's Daily Diary Pro Column: Top Stocks Pro Column: Stocks Under $10 What's New. …

thestreet.com

8%
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · Legend Biotech reported strong earnings in the third quarter of 2024, with total revenue reaching $160.2 million, a 66.8% increase from the same period last year.

insidermonkey.com

$2
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · In Q2 2024, BridgeBio Pharma, Inc. (NASDAQ:BBIO) reported revenue of $2.2 million, a slight increase from $1.6 million in Q2 2023. While this revenue growth is minimal, …

insidermonkey.com

$142.42
OFF

Biogen Stock At Lowest Level Since February 2013 Following J.P.

2 weeks from now

1 day ago · Veronique D. Biogen's (NASDAQ:BIIB) share price reached a low of $142.42 on Tuesday, the lowest level since February 2013 despite a company presentation at the J.P. …

seekingalpha.com

FAQs about Worst Performing Biotechnology Stocks Last 12 Months Coupon?

How did biotech stocks perform last year?

Last year, the average return for biotech IPOs was down by 15%, according to Jefferies analysts. Biotech stocks gained significant attention due to the pandemic in 2020, leading to an influx of capital and potentially inflated valuations, as noted by biotech investor Brad Loncar in December. ...

Which biotech stocks have outperformed the market this year?

This year, several biotech stocks have outperformed the struggling market. Vertex Pharmaceuticals (VRTX), Exelixis (EXEL), and Amgen (AMGN) have all seen positive returns, with Vertex Pharmaceuticals having the best performance at -1. 12%. ...

Will this year be a good year for biotech stocks?

Speaking with BNN Bloomberg's Amber Kanwar on Friday, Laura Chico, senior vice-president of biotechnology equity research at Wedbush, explained this year should be a great year for biotech stocks as many companies have made advancements in their pipelines and await FDA approvals. ...

Could biotech stocks climb higher this year?

This year, shares of the following three biotech stocks have soared and could climb even higher in the opposite direction of the overall market. Belite Bio (BLTE) is one of them, with a year-to-date increase of about 179%, in response to progress for its lead candidate. ...

Which are the best biotech stocks to buy in 2023?

According to WallStreetZen's Zen Score, the 3 best biotech stocks to buy in 2023 are: 1. Arcturus Therapeutics Holdings (NASDAQ: ARCT). ...

What are the best biotech stocks to buy right now?

According to Zen Score, the top 3 biotechnology stocks to buy right now are: Arcturus Therapeutics Holdings (NASDAQ: ARCT) with a Zen Score of 77, which is 53 points higher than the biotech industry average of 24. Arcturus Therapeutics Holdings (NASDAQ: ARCT) is one of the best biotech stocks to buy right now. ...